Fast-Track Grant will support ongoing preclinical development of a Vasculogenic Mimicry-blocking Antibody Fusion therapeutic for Triple Negative Breast Cancer Fast-Track Grant will support ongoing preclinical development of a Vasculogenic Mimicry-blocking Antibody Fusion therapeutic for Triple Negative Breast Cancer
See the article here:
Synergys Receives Third NIH SBIR Grant from National Cancer Institute
Recommendation and review posted by Fredricko
